153 related articles for article (PubMed ID: 19423428)
1. New decision support tool for treatment intensity choice in childhood acute lymphoblastic leukemia.
Pedreira CE; Macrini L; Land MG; Costa ES
IEEE Trans Inf Technol Biomed; 2009 May; 13(3):284-90. PubMed ID: 19423428
[TBL] [Abstract][Full Text] [Related]
2. GenSo-FDSS: a neural-fuzzy decision support system for pediatric ALL cancer subtype identification using gene expression data.
Tung WL; Quek C
Artif Intell Med; 2005 Jan; 33(1):61-88. PubMed ID: 15617982
[TBL] [Abstract][Full Text] [Related]
3. Treatment of childhood acute lymphoblastic leukemia.
Stanulla M; Schrappe M
Semin Hematol; 2009 Jan; 46(1):52-63. PubMed ID: 19100368
[TBL] [Abstract][Full Text] [Related]
4. Integrating molecular information into treatment of childhood acute lymphoblastic leukemia--a perspective from the BFM Study Group.
Stanulla M; Cario G; Meissner B; Schrauder A; Möricke A; Riehm H; Schrappe M
Blood Cells Mol Dis; 2007; 39(2):160-3. PubMed ID: 17532236
[TBL] [Abstract][Full Text] [Related]
5. Health-care providers' compliance with childhood acute lymphoblastic leukemia protocol in Indonesia.
Sitaresmi MN; Mostert S; Gundy CM; Sutaryo ; Veerman AJ
Pediatr Blood Cancer; 2008 Dec; 51(6):732-6. PubMed ID: 18816641
[TBL] [Abstract][Full Text] [Related]
6. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.
Uderzo C; Conter V; Dini G; Locatelli F; Miniero R; Tamaro P
Haematologica; 2001 Jan; 86(1):1-7. PubMed ID: 11146562
[No Abstract] [Full Text] [Related]
7. Treatment strategies and regimens of graduated intensity for childhood acute lymphoblastic leukemia in low-income countries: A proposal.
Hunger SP; Sung L; Howard SC
Pediatr Blood Cancer; 2009 May; 52(5):559-65. PubMed ID: 19127567
[TBL] [Abstract][Full Text] [Related]
8. Risk-adapted stratification and treatment of childhood acute lymphoblastic leukaemia.
Schrappe M
Radiat Prot Dosimetry; 2008; 132(2):130-3. PubMed ID: 19017727
[TBL] [Abstract][Full Text] [Related]
9. Optimizing the classification of acute lymphoblastic leukemia and acute myeloid leukemia samples using artificial neural networks.
Zong N; Adjouadi M; Ayala M
Biomed Sci Instrum; 2006; 42():261-6. PubMed ID: 16817618
[TBL] [Abstract][Full Text] [Related]
10. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
Burkhardt B; Reiter A; Landmann E; Lang P; Lassay L; Dickerhoff R; Lakomek M; Henze G; von Stackelberg A
J Clin Oncol; 2009 Jul; 27(20):3363-9. PubMed ID: 19433688
[TBL] [Abstract][Full Text] [Related]
11. [High-risk acute lymphoblastic leukemia. Results of a diagnostic-therapeutic protocol].
Castell V; Verdaguer A; Ferris J; Piqueras AI; Fernández JM
An Esp Pediatr; 1988 Oct; 29 Suppl 34():89-91. PubMed ID: 3214045
[No Abstract] [Full Text] [Related]
12. Clinical significance of minimal residual disease at day 15 and at the end of therapy in childhood acute lymphoblastic leukaemia.
Sutton R; Venn NC; Tolisano J; Bahar AY; Giles JE; Ashton LJ; Teague L; Rigutto G; Waters K; Marshall GM; Haber M; Norris MD;
Br J Haematol; 2009 Aug; 146(3):292-9. PubMed ID: 19500099
[TBL] [Abstract][Full Text] [Related]
13. LISA: a web-based decision-support system for trial management of childhood acute lymphoblastic leukaemia.
Bury J; Hurt C; Roy A; Cheesman L; Bradburn M; Cross S; Fox J; Saha V
Br J Haematol; 2005 Jun; 129(6):746-54. PubMed ID: 15953000
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of valvular heart disease through neural networks ensembles.
Das R; Turkoglu I; Sengur A
Comput Methods Programs Biomed; 2009 Feb; 93(2):185-91. PubMed ID: 18951649
[TBL] [Abstract][Full Text] [Related]
15. NCCN pediatric acute lymphoblastic leukemia practice guidelines. The National Comprehensive Cancer Network.
O'Reilly R; Pui CH; Kernan N; Sallan S; Sanders J; Steinherz P; Wharam M; Zipf T
Oncology (Williston Park); 1996 Dec; 10(12):1787-94. PubMed ID: 8985964
[No Abstract] [Full Text] [Related]
16. Non-classical karyotypic features in relapsed childhood B-cell precursor acute lymphoblastic leukemia.
Wehrli LA; Braun J; Buetti LN; Hagleitner N; Hengartner H; Kühne T; Lüer S; Ozsahin H; Popovic MB; Niggli FK; Betts DR; Bourquin JP
Cancer Genet Cytogenet; 2009 Feb; 189(1):29-36. PubMed ID: 19167609
[TBL] [Abstract][Full Text] [Related]
17. Cost of childhood acute lymphoblastic leukemia care in Shanghai, China.
Liu Y; Chen J; Tang J; Ni S; Xue H; Pan C
Pediatr Blood Cancer; 2009 Oct; 53(4):557-62. PubMed ID: 19526524
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of alternative prognostic stratifications by prediction accuracy measures on individual survival with application to childhood leukaemia.
De Lorenzo P; Antolini L; Valsecchi MG
Eur J Cancer; 2009 May; 45(8):1432-7. PubMed ID: 19223176
[TBL] [Abstract][Full Text] [Related]
19. [Treatment strategy for childhood acute lymphoblastic leukemia].
Horibe K
Rinsho Ketsueki; 2012 Oct; 53(10):1538-48. PubMed ID: 23037726
[No Abstract] [Full Text] [Related]
20. The absence of peripheral blood blasts at diagnosis may predict CNS involvement or CNS relapse in pediatric acute lymphoblastic leukemia patients.
Unal S; Tuncer AM; Cetin M; Yetgin S
Turk J Pediatr; 2008; 50(6):537-41. PubMed ID: 19227416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
